iSTAR Medical announces positive 5-year data from its STAR-GLOBAL trial for supraciliary MIGS device

Published on April 30, 2025
STAR-GLOBAL is an extension trial of the initial EU clinical trials investigating the long term safety and efficacy of MINIject in patients with up to 5 years of follow up.
Continue reading on website
Other news

How Optometrists Diagnose Diabetes

April 30, 2025
Diabetes mellitus is a group of metabolic disorders that is defined by the inability of the body to produce or respond to the hormone insulin. This can be the result of either defective insulin secretion, or target cell receptor resistance.No matter the cause, this disorder results in imbalanced carbohydrate metabolism and subsequent elevated blood glucose levels. While the bodily processes that l

University of Cincinnati researchers find fear of vision loss may be deterring patients from cataract surgery

April 30, 2025
Of participants surveyed, 36% reported a fear of cataract surgery, with more than half of those specifically feared it would lead to vision loss.